Search

Keith Neil Haffer

age ~72

from Canton, SD

Get Report
Also known as:
  • Keith N Haffer
  • Keith Neil Dr Haffer
  • Keith Living Haffer
  • Keith E Haffer
  • Keith K Haffer
  • Keith Hoffer
Related to:
Connected to:

Keith Haffer Phones & Addresses

  • Canton, SD
  • 421 Rose Ave, Sherman, SD 57030 • 605-594-6255
  • Garretson, SD
  • Lincoln, NE
  • Amherst, MA
  • Sioux Falls, SD
Name / Title
Company / Classification
Phones & Addresses
Keith Haffer
President
Advantage Bio Consultants
Biotechnology · Bio Consultant
PO Box 430, Garretson, SD 57030
421 Rose Ave, Garretson, SD 57030
605-594-6255
Keith N. Haffer
Principal Scientist
Braasch Biotech LLC
Biotechnology · Mfg Pharmaceutical Preparations
421 Rose Ave, Garretson, SD 57030
605-376-8752, 605-594-6256

Resumes

Keith Haffer Photo 1

Keith Haffer

view source
Location:
Sioux Falls, South Dakota Area
Industry:
Biotechnology
Keith Haffer Photo 2

President

view source
Location:
Sioux Falls, SD
Industry:
Biotechnology
Work:
Advantage Bio Consultants
President
Gsk Jul 1985 - Sep 1992
Director, Virology and Immunology Development
Sanofi Apr 1980 - Jul 1984
Manager, Vaccine Development
Purdue University Sep 1978 - Apr 1980
Postdoctoral Associate
Education:
University of Massachusetts Amherst 1976 - 1978
Doctorates, Doctor of Philosophy, Immunology, Virology University of Massachusetts Amherst 1974 - 1976
Master of Science, Masters, Immunology, Virology Boston University 1970 - 1974
Keith Haffer Photo 3

President And Chief Strategy Officer

view source
Location:
421 Rose Ave, Garretson, SD 57030
Industry:
Biotechnology
Work:
Braasch Biotech LLC since Jun 2008
President and CSO
Advantage Bio Consultants, Inc - Garretson, South Dakota since Jan 1994
President
Braasch Biotech Inc Jan 1998 - Nov 2008
President
ImmuCell Corporation Oct 2000 - May 2002
Board Member
Grand Laboratories Sep 1992 - Apr 1994
Director Strategic Planning and Research
Education:
University of Massachusetts, Amherst 1976 - 1978
University of Massachusetts, Amherst 1974 - 1976
Boston University Sep 1970 - May 1974
Skills:
Biotechnology
Vaccines
Immunology
Biopharmaceuticals
Life Sciences
Virology
R&D
Laboratory
Technology Transfer
Commercialization
Molecular Biology
Pharmaceutical Industry
Microbiology
Antibodies
Dna
Infectious Diseases
Drug Development
Lifesciences
Veterinary
Protein Chemistry
Biochemistry
Biologics
Product Development
Strategic Planning
Cell Culture
Cell Biology
Glp
Clinical Development
Regulatory Affairs
Drug Delivery
Genomics
Toxicology
Pcr
Pharmacology
Assay Development
Quality Systems
Biosafety
Quality System
Chromatography
Immunoassays
Research
Business Strategy
Management
Technology Commercialization
Expert Witness
Gmp
Drug Discovery
Medical Diagnostics
M&A Advisory Services
International Project Management
Interests:
Social Services
Children
Cooking
Oes
Environment
Education
Photography
Science and Technology
Disaster and Humanitarian Relief
Human Rights
Equine Studies
Animal Welfare
Health
Languages:
French

Us Patents

  • Chloramphenicol Acetyl Transferase (Cat)-Defective Somatostatin Fusion Protein And Uses Thereof

    view source
  • US Patent:
    7943143, May 17, 2011
  • Filed:
    Feb 10, 2010
  • Appl. No.:
    12/703631
  • Inventors:
    Andrew R. Mendelsohn - Sunnyvale CA, US
    Keith N. Haffer - Garretson SD, US
    James Larrick - Sunnyvale CA, US
  • Assignee:
    Braasch Biotech LLC - Garretson SD
  • International Classification:
    A61K 39/00
  • US Classification:
    4241981, 4241851, 530311
  • Abstract:
    Chimeric somatostatin-based polypeptides, polynucleotides used to encode the polypeptides, the methods for isolating and producing the polypeptides and the uses thereof are provided. In addition, low cost adjuvants for enhanced immunogenic response are provided. Vaccinations that include both chimeric somatostatin-based polypeptides and novel adjuvants are included, useful in facilitating farm animal productivity.

  • Chloramphenicol Acetyl Transferase (Cat)-Defective Somatostatin Fusion Protein And Uses Thereof

    view source
  • US Patent:
    8367073, Feb 5, 2013
  • Filed:
    Mar 23, 2011
  • Appl. No.:
    13/069592
  • Inventors:
    Andrew R. Mendelsohn - Sunnyvale CA, US
    Keith N. Haffer - Garretson SD, US
    James Larrick - Sunnyvale CA, US
  • Assignee:
    Braasch Biotech, LLC - Garretson SD
  • International Classification:
    A61K 39/00
  • US Classification:
    4241981, 4241851, 530311
  • Abstract:
    Chimeric somatostatin-based polypeptides, polynucleotides used to encode the polypeptides, the methods for isolating and producing the polypeptides and the uses thereof are provided. In addition, low cost adjuvants for enhanced immunogenic response are provided. Vaccinations that include both chimeric somatostatin-based polypeptides and novel adjuvants are included, useful in facilitating farm animal productivity.

  • Methods For Enhanced Somatostatin Immunogenicity In The Treatment Of Obesity

    view source
  • US Patent:
    8425914, Apr 23, 2013
  • Filed:
    Jun 24, 2009
  • Appl. No.:
    12/523952
  • Inventors:
    Keith N. Haffer - Garretson SD, US
    James Larrick - Sunnyvale CA, US
    Andrew R. Mendelsohn - Sunnyvale CA, US
  • Assignee:
    Braasch Biotech LLC - Garretson SD
  • International Classification:
    C07K 14/655
    C12N 9/1033
    A61K 2039/55566
    C07K 2319/00
    C07K 2319/31
  • US Classification:
    4241851, 4241981, 4242781, 514909
  • Abstract:
    Compositions and methods are provided for treatment growth hormone and/or insulin-like growth factor 1 deficiency in a patient in need of such treatment. Compositions and methods include novel vaccines that provide immunogenicity for somatostatin and result in the increased release of endogenously produced growth hormone and/or insulin-like growth factor 1.

  • Chloramphenicol Acetyl Transferase (Cat)-Defective Somatostatin Fusion Protein And Uses Thereof

    view source
  • US Patent:
    20090324629, Dec 31, 2009
  • Filed:
    Aug 26, 2008
  • Appl. No.:
    12/198579
  • Inventors:
    Andrew R. Mendelsohn - Mountain View CA, US
    Keith N. Haffer - Garretson SD, US
    James Larrick - Mountain View CA, US
  • Assignee:
    BRAASCH BIOTECH LLC - Garretson SD
  • International Classification:
    A61K 39/00
    C12N 9/10
  • US Classification:
    4241851, 435193, 4242801
  • Abstract:
    Chimeric somatostatin-based polypeptides, polynucleotides used to encode the polypeptides, the methods for isolating and producing the polypeptides and the uses thereof are provided. In addition, low cost adjuvants for enhanced immunogenic response are provided. Vaccinations that include both chimeric somatostatin-based polypeptides and novel adjuvants are included, useful in facilitating farm animal productivity.

  • Methods For Improving Immunological Response In Vaccinated Animals

    view source
  • US Patent:
    20190374634, Dec 12, 2019
  • Filed:
    Aug 27, 2019
  • Appl. No.:
    16/552442
  • Inventors:
    - Garretson SD, US
    Keith N. Haffer - Garretson SD, US
  • International Classification:
    A61K 39/385
    A61K 39/00
  • Abstract:
    A method is provided for increasing an immunological response to a target antigen in an animal by administering an immunogenic amount of a vaccine comprising a polypeptide conjugate comprising the target antigen conjugated to a carrier polypeptide by means of a linker polypeptide which is rich in predicted linear B-cell epitopes.

  • Methods For Improving Immunological Response In Vaccinated Animals

    view source
  • US Patent:
    20160051668, Feb 25, 2016
  • Filed:
    Aug 20, 2015
  • Appl. No.:
    14/831602
  • Inventors:
    - Garretson SD, US
    Keith N. Haffer - Garretson SD, US
  • International Classification:
    A61K 39/385
    A61K 39/00
  • Abstract:
    A method is provided for increasing an immunological response to a target antigen in an animal by administering an immunogenic amount of a vaccine comprising a polypeptide conjugate comprising the target antigen conjugated to a carrier polypeptide by means of a linker polypeptide which is rich in predicted linear B-cell epitopes.

Googleplus

Keith Haffer Photo 4

Keith Haffer

Work:
Advantage Bio Consultants - President (1994)
Braasch Biotech LLC - President & CSO (2008)
Education:
University of Massachusetts Amherst - Veterinary Sciences
Get Report for Keith Neil Haffer from Canton, SD, age ~72
Control profile